Literature DB >> 30072501

Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques.

Nicholas Voutsinas1, Safet Lekperic2, Sharon Barazani2, Joseph J Titano2, Sherif I Heiba2, Edward Kim2.   

Abstract

90Y radioembolization is an increasingly used treatment for both primary and metastatic malignancy in the liver. Understanding the biophysical properties, dosing concerns, and imaging appearance of this treatment is important for interventional radiologists and nuclear medicine physicians to provide important therapy. 90Y radioembolization is efficacious and safe, although the possibility of complications does exist. This article provides a comprehensive in-depth discussion about the indications for 90Y radioembolization, reviews the role of preprocedural angiography and 99mTc-macroaggregated albumin scans, illustrates different dosing techniques, compares and contrasts resin and glass microspheres, and describes potential complications.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  90Y radioembolization; MAA; hepatocellular carcinoma; liver, cancer

Mesh:

Substances:

Year:  2018        PMID: 30072501     DOI: 10.2967/jnumed.116.186346

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  In Vivo Models for the Performance and Safety of BAT-90, a Novel 90-Yttrium-based Internal Radiotherapy Platform.

Authors:  Antonino Amato; Gordon McVie; Giovanni Paganelli; Pier Luigi Carriero; Roberto Cianni; Giuseppe Maria Ettorre
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 2.  Radioembolization for the Treatment of Primary and Metastatic Liver Cancers.

Authors:  Eun Jeong Lee; Hyun Woo Chung; Joon-Hyung Jo; Young So
Journal:  Nucl Med Mol Imaging       Date:  2019-11-08

Review 3.  Mechanistic connections between mitochondrial biology and regulated cell death.

Authors:  Jerry Edward Chipuk; Jarvier N Mohammed; Jesse D Gelles; Yiyang Chen
Journal:  Dev Cell       Date:  2021-04-21       Impact factor: 12.270

4.  High quality imaging and dosimetry for yttrium-90 (90Y) liver radioembolization using a SiPM-based PET/CT scanner.

Authors:  Heying Duan; Mohamed H Khalaf; Valentina Ferri; Lucia Baratto; Shyam M Srinivas; Daniel Y Sze; Andrei Iagaru
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-14       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.